Permana A, Akili A, Hardianto A, Latip J, Sulaeman A, Herlina T
Adv Appl Bioinform Chem. 2025; 17:179-201.
PMID: 39931375
PMC: 11808975.
DOI: 10.2147/AABC.S495947.
Kleandrova V, Cordeiro M, Speck-Planche A
BMC Chem. 2025; 19(1):2.
PMID: 39748442
PMC: 11697510.
DOI: 10.1186/s13065-024-01376-z.
van den Maagdenberg H, Sicho M, Araripe D, Luukkonen S, Schoenmaker L, Jespers M
J Cheminform. 2024; 16(1):128.
PMID: 39543652
PMC: 11566221.
DOI: 10.1186/s13321-024-00908-y.
Steurer B, Vanhaelen Q, Zhavoronkov A
J Gerontol A Biol Sci Med Sci. 2024; 79(9).
PMID: 39126345
PMC: 11316220.
DOI: 10.1093/gerona/glae006.
Yu M, Shen Z, Zhang S, Zhang Y, Zhao H, Zhang L
Heliyon. 2024; 10(13):e33761.
PMID: 39027618
PMC: 11255520.
DOI: 10.1016/j.heliyon.2024.e33761.
Drug repurposing for obsessive-compulsive disorder using deep learning-based binding affinity prediction models.
Papikinos T, Krokidis M, Vrahatis A, Vlamos P, Exarchos T
AIMS Neurosci. 2024; 11(2):203-211.
PMID: 38988885
PMC: 11230860.
DOI: 10.3934/Neuroscience.2024013.
Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors.
Shah S, Chaple D, Masand V, Jawarkar R, Chaudhari S, Abiramasundari A
Sci Rep. 2024; 14(1):15991.
PMID: 38987327
PMC: 11237057.
DOI: 10.1038/s41598-024-66230-7.
Using interactive Jupyter Notebooks and BioConda for FAIR and reproducible biomolecular simulation workflows.
Bayarri G, Andrio P, Gelpi J, Hospital A, Orozco M
PLoS Comput Biol. 2024; 20(6):e1012173.
PMID: 38900779
PMC: 11189206.
DOI: 10.1371/journal.pcbi.1012173.
Anomaly detection for high-content image-based phenotypic cell profiling.
Shpigler A, Kolet N, Golan S, Weisbart E, Zaritsky A
bioRxiv. 2024; .
PMID: 38895267
PMC: 11185510.
DOI: 10.1101/2024.06.01.595856.
Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction.
Myung Y, de Sa A, Ascher D
Nucleic Acids Res. 2024; 52(W1):W469-W475.
PMID: 38634808
PMC: 11223837.
DOI: 10.1093/nar/gkae254.
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis.
Berhe H, Kumar Cinthakunta Sridhar M, Zerihun M, Qvit N
Pharmaceutics. 2024; 16(2).
PMID: 38399281
PMC: 10892537.
DOI: 10.3390/pharmaceutics16020227.
Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS.
Geraci J, Bhargava R, Qorri B, Leonchyk P, Cook D, Cook M
Front Comput Neurosci. 2024; 17:1199736.
PMID: 38260713
PMC: 10801647.
DOI: 10.3389/fncom.2023.1199736.
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis.
Niazi S, Mariam Z
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256856
PMC: 10819513.
DOI: 10.3390/ph17010022.
Measuring the Impact of Data Sharing: From Author-Level Metrics to Quantification of Economic and Non-tangible Benefits.
Emanuele E, Minoretti P
Cureus. 2024; 15(12):e50308.
PMID: 38205488
PMC: 10777335.
DOI: 10.7759/cureus.50308.
Virtual Screening and ADMET Prediction to Uncover the Potency of Flavonoids from Genus as Antibacterial Agent through Inhibition of Bacterial ATPase DNA Gyrase B.
Akili A, Hardianto A, Latip J, Permana A, Herlina T
Molecules. 2023; 28(24).
PMID: 38138500
PMC: 10745610.
DOI: 10.3390/molecules28248010.
NMR and Docking Calculations Reveal Novel Atomistic Selectivity of a Synthetic High-Affinity Free Fatty Acid vs. Free Fatty Acids in Sudlow's Drug Binding Sites in Human Serum Albumin.
Venianakis T, Primikyri A, Opatz T, Petry S, Papamokos G, Gerothanassis I
Molecules. 2023; 28(24).
PMID: 38138481
PMC: 10745614.
DOI: 10.3390/molecules28247991.
Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations.
Alrouji M, Alhumaydhi F, Alsayari A, Sharaf S, Shafi S, Anwar S
PLoS One. 2023; 18(12):e0293185.
PMID: 38117829
PMC: 10732437.
DOI: 10.1371/journal.pone.0293185.
Quantitative Structure-Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity.
Khairullina V, Martynova Y
Molecules. 2023; 28(23).
PMID: 38067446
PMC: 10708366.
DOI: 10.3390/molecules28237715.
From intuition to AI: evolution of small molecule representations in drug discovery.
McGibbon M, Shave S, Dong J, Gao Y, Houston D, Xie J
Brief Bioinform. 2023; 25(1).
PMID: 38033290
PMC: 10689004.
DOI: 10.1093/bib/bbad422.
Machine Learning Approaches to Investigate the Structure-Activity Relationship of Angiotensin-Converting Enzyme Inhibitors.
Yu T, Nantasenamat C, Anuwongcharoen N, Piacham T
ACS Omega. 2023; 8(46):43500-43510.
PMID: 38027387
PMC: 10666249.
DOI: 10.1021/acsomega.3c03225.